Brief: Suven Life Sciences gets product patent in New Zealand
Oct 10 (Reuters) - Suven Life Sciences Ltd SUVP.NS
* Says co secures a product patent in New Zealand
* Says patents are valid through 2034
* Product patent corresponds to New Chemical Entities (NCEs)
for treatment of disorders associated with neurodegenerative
diseases
Source text - http://bit.ly/2g83faN
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees